№ lp_1_2_11441
File format: docx Character count: 4619 File size: 73 KB
Note: Date
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Project Study Report-Project Development Support (PSR-PDS)ToRequest Programming for Capital Support(Project Approval and Environmental Document Phase) (in the 20__ STIP)*(*For a locally sponsored project, this language may not be included or may need to be modified.)
Year: 20__
Note: Region/City
Document Type: Project Study Report
REQUEST FOR EXPRESSIONS OF INTEREST (REOI) FOR INDIVIDUAL CONSULTANTSRe-AdvertisementConsultancy Service to develop training materials on the regulation of research, development Ethical considerations, and release of genetically modified gene drive mosquitoes for vector control, communication and stakeholder engagements and international engagements
Year: 2024
Region / City: Africa
Topic: Vector Control, Malaria, Genetically Modified Organisms
Document Type: Consultancy Announcement
Organization: African Union Development Agency-NEPAD (AUDA-NEPAD)
Author: Not specified
Target Audience: Individual Consultants
Period of Validity: Not specified
Approval Date: Not specified
Modification Date: Not specified
Activating Identities and Futures: Modified (Stage 2) Subject Outline Version 1.0
Year: 2025
Region / city: Australia
Theme: Education
Document Type: Subject Outline
Organ / institution: SACE Board
Author: SACE Board
Target audience: Educational institutions, teachers, students
Period of validity: From 2024 for pilot schools, from 2025 for all schools
Approval date: Not specified
Date of changes: Not specified
The document outlines the Stage 2 subject "Activating Identities and Futures: Modified" as accredited by the SACE Board, including curriculum requirements and pathways for students eligible for modified subjects.
DAPAGLIFLOZIN AND METFORMIN XR (FDC), modified release tablets, 10 mg/500 mg, 10 mg/1000 mg, 5 mg/1000 mg, Xigduo XR®, AstraZeneca Pty Ltd
Year: 2014
Region / city: Australia
Topic: Pharmaceutical product submission
Document type: Application for listing
Organization / institution: Pharmaceutical Benefits Advisory Committee (PBAC)
Author: AstraZeneca Pty Ltd
Target audience: Health professionals, regulatory authorities
Period of validity: Not specified
Approval date: Not specified
Date of changes: 1 April 2014
All games at all Parks will be played in accordance with National Federation of High School (NFHS) rules unless otherwise modified by the following rules.
Year: 2017
Region / City: United States
Theme: Youth Baseball Rules
Document Type: Sports Rules
Organization / Institution: USA Baseball
Author: National Federation of High School
Target Audience: Coaches, Players, Parents
Effective Period: 2017-2018
Approval Date: 2017
Date of Changes: 2017
Context: A set of modified rules for youth baseball games, primarily under the supervision of USA Baseball, including specific guidelines for pitching, bat standards, and player substitutions.
LATEX MODIFIED CONCRETE OVERLAY – Very Early Strength (11-30-23)
Year: 2023
Region / City: N/A
Theme: Construction, Concrete, Bridge Decks
Document Type: Special Provision
Agency / Institution: N/A
Author: N/A
Target Audience: Contractors, Engineers
Effective Period: N/A
Approval Date: N/A
Revision Date: N/A
LATEX MODIFIED CONCRETE OVERLAY – Very Early Strength (08-08-22)
Year: 2022
Region / City: Not specified
Theme: Concrete Overlay, Bridge Deck Repair
Document Type: Technical Specification
Organization / Institution: Not specified
Author: Not specified
Target Audience: Contractors, Engineers
Period of Validity: Not specified
Approval Date: Not specified
Modification Date: Not specified
5.01 ARIPIRAZOLE, I.M. injection (modified release) 720 mg in 2.4 mL pre-filled syringe, I.M. injection (modified release) 960 mg in 3.2 mL pre-filled syringe, Abilify Asimtufii®, Lundbeck Australia Pty Ltd
Year: 2024
Region / City: Australia
Topic: Medical submission for listing of Aripiprazole 2-monthly injection
Document Type: Submission for drug listing
Organization: Pharmaceutical Benefits Advisory Committee (PBAC)
Author: Lundbeck Australia Pty Ltd
Target Audience: Healthcare professionals, regulatory bodies
Period of validity: Not specified
Approval Date: Not specified
Date of Changes: Not specified
Modified HARmonized Protocol Template to Enhance Reproducibility – HARPER+CMS
Year: 2023
Region / city: United States
Topic: Medical Research, Protocol Template
Document type: Template, Research Protocol
Organization: CMS
Author: HARPER+CMS Team
Target audience: Medical researchers, manufacturers, study sponsors
Period of validity: Indefinite
Approval date: Not specified
Amendment date: Not specified
Consultation on applications for authorisation of regulated products: one food additive, one feed additive (new specification), one food flavouring and the removal of eight permitted food flavourings, one food contact material, two novel foods and three genetically modified organisms for food and feed uses
Year: 2025
Region / city: Scotland
Subject: Food safety, food additives, feed additives, novel foods, genetically modified organisms
Document type: Consultation
Organization: Food Standards Scotland
Author: Food Standards Scotland
Target audience: Scottish food and feed businesses, local and district councils, and other stakeholders with an interest in food and feed safety
Period of validity: From 8th January 2025 to 5th March 2025
Approval date: 8th January 2025
Date of amendments: N/A
Title of the Paper AuthorsAffiliation, CountryThis template, modified in MS Word 2007 and saved as a “Word 97-2003 Document” for the PC, provides authors with most of the formatting specifications needed for preparing electronic versions of their papers.
Note: Year
CIF for Voting Systems: A Modified Common Industry Format Template for Reporting on Usability Testing of Voting Systems
Year: 2023
Region / City: United States
Topic: Usability testing of voting systems
Document Type: Template
Organization / Institution: National Institute of Standards and Technology (NIST)
Author: NIST Voting Program
Target Audience: Voting manufacturers, usability test administrators
Period of Validity: Ongoing
Approval Date: 2023-02-01
Modification Date: N/A
CIF for Voting Systems: Guidelines on How to Complete the Modified CIF Template for Voting Manufacturers
Year: 2026
Region / City: USA
Subject: Voting Systems Usability Testing
Document Type: Guideline
Institution: National Institute of Standards and Technology (NIST)
Author: NIST Voting Program
Target Audience: Voting system manufacturers, Usability testers, Election administrators
Period of Validity: N/A
Approval Date: N/A
Date of Changes: N/A
Modified Competency Determination – Frequently Asked Questions
Year: 2020-2023
Region / City: Massachusetts
Subject: Education, Competency Determination
Document Type: Guidelines / FAQ
Institution: Massachusetts Department of Elementary and Secondary Education (DESE)
Author: Massachusetts Department of Elementary and Secondary Education (DESE)
Target Audience: School districts, educators, administrators
Period of Validity: 2020-2023
Approval Date: April 2020
Modification Date: 2024 (planned for August)
METHYLPHENIDATE Capsule containing methylphenidate hydrochloride 10 mg, 20 mg, 30 mg 40 mg and 60 mg (modified release), Ritalin® LA, Novartis Pharmaceuticals Australia Pty Limited
Year: 2021
Region / City: Australia
Topic: Pharmaceutical submission
Document type: Submission report
Organization: Novartis Pharmaceuticals Australia Pty Limited
Author: Novartis Pharmaceuticals Australia Pty Limited
Target audience: Healthcare professionals, regulatory bodies
Period of validity: Ongoing
Approval date: 21 August 2002
Date of revisions: 18 December 2009, 11 March 2016, 8 July 2021, 16 July 2021, 29 July 2021
Note: Contextual description
PROJECT OFFER INFORMATION
Note: Year
Offer of Dedication Multi-Purpose Easement
Note: Year
Region / City: Placer County, CA
Subject: Property easement dedication
Document Type: Legal Instrument
Organization / Institution: County of Placer
Offer for FinFisher Portfolio
Note: Year
Offeror Information and Terms for Offer Submission
Year: N/A
Region / City: N/A
Subject: Offer Submission and Compliance
Document Type: Offer Form
Organization / Institution: N/A
Author: N/A
Target Audience: Offerors
Effective Period: N/A
Approval Date: N/A
Amendment Date: N/A
Summary of Offer
Year: 2026
Region / City: Not specified
Subject: Offeror Information and Terms
Document Type: Form
Organization / Institution: Not specified
Author: Not specified
Target Audience: Contractors and suppliers
Period of Validity: Not specified
Approval Date: Not specified
Amendment Date: Not specified
Topics: modified OFFER Work